Strathspey Crown Acquires Assets of Novus Via

Jan 11, 2016, 19:22 ET from Strathspey Crown Holdings LLC

NEWPORT BEACH, Calif., Jan. 11, 2016 /PRNewswire/ -- Strathspey Crown Holdings LLC announced today the acquisition of the portfolio companies of Novus Via LP, a Nevada-based venture capital investment firm focused on end-stage development and commercialization of advanced electromagnetic and electrochemical technologies spanning healthcare, clean energy and coherent acoustics.  The terms of the transaction were not disclosed.

Robert E. Grant, Chairman of Strathspey Crown Holdings LLC, said, "Novus Via LP brings tremendous intellectual property and technical capabilities into our firm, significantly accelerating our development efforts in medical-grade wearable technology.  This transaction also marks our first diversification into advanced clean energy technologies and coherent acoustics.  We welcome the management of Novus Via LP and its portfolio companies into the growing global family of Strathspey Crown companies."

Peter F. Capuciati, Manager and General Partner of Novus Via LP said, "We are very pleased to join the Strathspey Crown portfolio of companies.  This transaction brings the Novus Via LP companies access to Strathspey's significant marketing and healthcare channel access, intellectual property, and public policy resources to advance their operating objectives."  Capuciati went on to add, "Strathspey is uniquely positioned to lead the rapidly emerging field of medical-grade wearable technologies and we are proud to work together to accelerate this exciting field of development and commercialization."

About Strathspey Crown Holdings LLC
Strathspey Crown is a growth equity firm specializing in lifestyle healthcare. The firm is founded in partnership with physician investors across key medical specialties including plastic surgery, ophthalmology, dermatology, dentistry and orthopedics. For more information, please visit

About Novus Via LP
Novus Via LP is a unique venture capital investment firm that accelerates and funds end-stage development and commercialization of advanced electromagnetic and electrochemical technologies spanning healthcare, clean energy and coherent acoustics.   For more information please visit

The Novus Via LP assets included in the transaction include controlling interests in the following companies:

Bluon Energy, LLC, a developer and manufacturer of next generation, energy efficient refrigerants, utilizing a novel approach to solve to the impending R-22 phase-out dilemma.  Bluon's TdX 20 is the first replacement for R-22 that upgrades an HVAC-R system's performance without the need for any new costly equipment or infrastructure.  For more information, please visit

Luminas International, LLC, an innovative developer and manufacturer in the newest electroceutical charging technology. This proprietary technology is now being used to for pain and chronic inflammation.  For more information, please visit

ThrivalTech, LLC, a developer of innovative plasma based electromagnetic technologies.  ThrivalTech's patented VIPER technology enables virtually emission free output from internal combustion engines.  

REVx Technologies, Inc. and its operating subsidiary REVx Acoustics, are the developer and manufacturer of a novel new coherent acoustic technology currently utilized in their REV33 product.  The technology removes distortion and magnetic interference from audio signals to substantially reduce ear fatigue and reduces the potential for related hearing loss while improving signal fidelity. For more information, please visit

GFO Oil, LLC, manufactures produces and sells the GFO Oil Additive which removes carbon buildup and restores combustion engine compression in addition to increasing lubricity.  GFO is 100% biodegradable.  For more information, please visit

Colorado Energy Research Technologies, Inc. (CERT), LLC.  CERT played a key role with Novus Via LP entities in the development of Bluon TdX20, the REV33, GFO and Luminas technology working.  CERT has unique skills in physics, biomedical and electrical engineering, analog electromagnetics, electrochemicals, coherent acoustics, and mechanical engineering.

Suzi Tack Director, Strathspey Crown
Tel: +1-949-260-1700

Logo -

SOURCE Strathspey Crown Holdings LLC